3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      HPV self-sampling acceptability in rural and indigenous communities in Guatemala: a cross-sectional study

      research-article

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          Cervical cancer disproportionately burdens low-income and middle-income countries (LMICs) such as Guatemala. Self-collection testing for human papillomavirus (HPV) has been suggested as a form of cervical cancer screening to facilitate access in LMICs. This study assessed and compared the acceptability of self-collection HPV testing in two rural, indigenous and ethnically distinct communities in Guatemala: Santiago Atitlán, Sololá and Livingston, Izabal.

          Methods

          All participants, women between the ages of 18 and 60, completed a questionnaire. Eligible participants were also asked to self-collect a vaginal sample and complete a questionnaire regarding comfort and acceptability. Self-collected samples were tested for high-risk HPV using the real-time PCR Hybribio kit.

          Results

          In the indigenous community of Santiago Atitlán, of 438 age-eligible participants, 94% completed self-collection. Of those, 81% found it comfortable and 98% were willing to use it as a form of screening. In the multiethnic (Afro-Caribbean, indigenous) community of Livingston, of 322 age-eligible participants, 53% chose to self-collect. Among those who took the test, 83% found it comfortable and 95% were willing to use it as a form of screening. In Livingston, literacy (can read and/or write vs cannot read or write) was higher in women who chose to self-collect (prevalence ratio 2.25; 95% CI 1.38 to 3.68). Ethnicity, history of screening and reproductive history were not associated with willingness to self-collect in Livingston. Women in Santiago reported less prior use of healthcare than women in Livingston. Overall, 19% (106/549) of samples tested positive for high-risk HPV.

          Conclusion

          Among women willing to self-collect in rural and indigenous communities in Guatemala, self-collection for HPV testing is highly acceptable. However, willingness to try self-collection might vary across communities and settings. Women from a community that used less healthcare were more likely to choose self-collection. Further research is necessary to determine what factors influence a woman’s choice to self-collect.

          Related collections

          Most cited references31

          • Record: found
          • Abstract: found
          • Article: not found

          Screening for Cervical Cancer

          The number of deaths from cervical cancer in the United States has decreased substantially since the implementation of widespread cervical cancer screening and has declined from 2.8 to 2.3 deaths per 100 000 women from 2000 to 2015.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.

            Screening for cervical cancer precursors by cytology has been very successful in countries where adequate resources exist to ensure high quality and good coverage of the population at risk. Mortality reductions in excess of 50% have been achieved in many developed countries; however the procedure is generally inefficient and unworkable in many parts of the world where the appropriate infrastructure is not achievable. A summary and update of recently published meta-analyses and systematic reviews on four possible clinical applications of human papillomavirus (HPV) DNA testing is provided in this article: (1) triage of women with equivocal or low-grade cytological abnormalities; (2) follow-up of women with abnormal screening results who are negative at colposcopy/biopsy; (3) prediction of the therapeutic outcome after treatment of cervical intraepithelial neoplasia (CIN), and most importantly (4) primary screening HPV DNA test, solely or in combination with Pap smear to detect cervical cancer precursors. There are clear benefits for the use of HPV DNA testing in the triage of equivocal smears, low-grade smears in older women and in the post-treatment surveillance of women after treatment for CIN. However, there are still issues regarding how best to use HPV DNA testing in primary screening. Primary screening with Hybrid Capture((R)) 2 (HC2) generally detects more than 90% of all CIN2, CIN3 or cancer cases, and is 25% (95% CI): 15-36%) relatively more sensitive than cytology at a cut-off of abnormal squamous cells of undetermined significance (ASC-US) (or low-grade squamous intraepithelial lesions (LSIL) if ASC-US unavailable), but is 6% (95% CI: 4-7%) relatively less specific. Several approaches are currently under evaluation to deal with the lower specificity of HPV DNA testing as associated with transient infection. These include HPV typing for HPV-16 and -18/45, markers of proliferative lesions such as p16 and mRNA coding for the viral E6 and/or E7 proteins, with a potential clinical use recommending more aggressive management in those who are positive. In countries where cytology is of good quality, the most attractive option for primary screening is to use HPV DNA testing as the sole screening modality with cytology reserved for triage of HPV-positive women. Established cytology-based programmes should also be gradually moving towards a greater use of HPV DNA testing to improve their efficacy and safely lengthen the screening interval. The greater sensitivity of HPV DNA testing compared to cytology argues strongly for using HPV DNA testing as the primary screening test in newly implemented programmes, except where resources are extremely limited and only programmes based on visual inspection are affordable. In such countries, use of a simple HPV DNA test followed by immediate 'screen and treat' algorithms based on visual inspection in those who are HPV-positive are needed to minimise the number of visits and make best use of limited resources. A review of studies for visual inspection methods is presented. The fact that HPV is a sexually transmitted infection may lead to anxiety and concerns about sexual relationships. These psychosocial aspects and the need for more information and educational programmes about HPV are also discussed in this article.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found
              Is Open Access

              Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial.

              Control of cervical cancer in developing countries has been hampered by a failure to achieve high screening uptake. HPV DNA self-collection could increase screening coverage, but implementation of this technology is difficult in countries of middle and low income. We investigated whether offering HPV DNA self-collection during routine home visits by community health workers could increase cervical screening.
                Bookmark

                Author and article information

                Journal
                BMJ Open
                BMJ Open
                bmjopen
                bmjopen
                BMJ Open
                BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
                2044-6055
                2019
                28 October 2019
                : 9
                : 10
                : e029158
                Affiliations
                [1 ] departmentEpidemiology , University of Michigan School of Public Health , Ann Arbor, Michigan, USA
                [2 ] departmentCenter for the Prevention of Chronic Diseases , Instituto de Nutricion de Centroamerica y Panama , Guatemala, Guatemala
                [3 ] departmentFunctional Nutrition, Oxidation, and Cardiovascular Diseases Group (NFOC-Salut) , Universitat Rovira i Virgili, Hospital Universitari Sant Joan , Reus, Spain
                [4 ] departmentClinical Prevention Services , BC Centre for Disease Control , Vancouver, British Columbia, Canada
                [5 ] departmentDepartment of Otolaryngology-Head and Neck Surgery and Department of Pharmacology , University of Michigan , Ann Arbor, Michigan, USA
                [6 ] departmentDepartment of Otolaryngology Head and Neck Surgery , University of Michigan , Ann Arbor, Michigan, USA
                [7 ] departmentLaboratory of Translational Genomics, Division of Cancer, Epidemiology and Genetics , National Cancer Institute , Gaithersburg, Maryland, USA
                [8 ] departmentCancer Epidemiology and Prevention Program , University of Michigan Rogel Cancer Center , Ann Arbor, United States
                Author notes
                [Correspondence to ] Dr Rafael Meza; rmeza@ 123456umich.edu
                Article
                bmjopen-2019-029158
                10.1136/bmjopen-2019-029158
                6830827
                31662358
                ba9fcd61-e474-42d1-af6c-4cb24d7e7770
                © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

                This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:  http://creativecommons.org/licenses/by-nc/4.0/.

                History
                : 14 January 2019
                : 16 August 2019
                : 02 September 2019
                Funding
                Funded by: The University of Michigan Department of Latin American and Caribbean Studies;
                Award ID: The Tinker Grant
                Funded by: The University of Michigan Center for the Education of Women;
                Funded by: The University of British Columbia’s School of Population and Public Health and Faculty of Medicine;
                Award ID: CIHR Foundation Scheme: Integrated Global Control
                Funded by: The University of Michigan’s School of Public Health Office of Global Public Health and Department of Epidemiology;
                Funded by: The University of Michigan M-Cubed Program;
                Categories
                Epidemiology
                Original Research
                1506
                1692
                Custom metadata
                unlocked

                Medicine
                public health,epidemiology
                Medicine
                public health, epidemiology

                Comments

                Comment on this article